Publications by authors named "M Knetki-Wroblewska"

Article Synopsis
  • Many patients with advanced cancer, like tracheal cancers, can't be cured, making palliative care vital.
  • Existing studies mostly look at palliative care as part of broader cancer treatments and don't focus solely on tracheal tumors.
  • This review presents the first detailed clinical guidelines for palliative treatment specifically for tracheal cancer, addressing unique challenges not covered by other cancer treatment guidelines.
View Article and Find Full Text PDF

Context: Nonsmall Cell Lung Cancer (NSCLC) treatment relies on first-line immunotherapy as single agent or combined with chemotherapy. Oligoprogression may be observed in this setting.

Material And Method: We performed a European multicentric retrospective study on patients treated with first-line immunotherapy, who presented with oligoprogressive disease, treated with a local ablative treatment.

View Article and Find Full Text PDF

Pulmonary benign metastasizing leiomyoma (PBML) is a rare condition characterized by the spread of uterine leiomyomas to the lungs, typically observed in premenopausal women with a history of hysterectomy or myomectomy. This report presents a unique case of a postmenopausal woman, aged 65, that emphasizes the clinical, radiological, histologic, and immunohistochemical aspects of the disease. On presentation, the patient suffered from severe pain.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the effect of PD-L1 expression levels on overall survival (OS) in stage IV non-small cell lung cancer (NSCLC) patients treated with pembrolizumab.
  • A total of 617 patients from multiple oncology centers were analyzed, categorized by PD-L1 expression levels (≥50%).
  • The results indicated no significant difference in OS related to varying PD-L1 expression levels, suggesting that higher PD-L1 levels do not correlate with improved survival outcomes in these patients.
View Article and Find Full Text PDF

Objective: Primary tracheal tumors are very rare and their management is not definitely established. Due to its rarity, providing patient care in terms of optimal management poses a considerable challenge. The purpose of this study was to investigate treatment outcomes in patients with these rare tumors.

View Article and Find Full Text PDF